| Author |
Subjects (%) |
Before
LTx |
After
LTx |
Indications for LTx |
Time of
follow-up |
Adverse outcome related to MS |
| Laish[20]a |
252 |
221 |
252 |
various |
6mths-15yrs |
More CVD |
| Obesity |
|
24 (10.8) |
69 (27.5) |
|
|
|
| Diabetes mellitus |
|
32 (14.4) |
100 (39.6) |
|
|
|
| Hypertension |
|
19 (8.6) |
147 (58.3) |
|
|
|
| Low HDL |
|
87 (39.8) |
123 (48.8) |
|
|
|
| Abnormal TG |
|
16 (7.2) |
119 (47.2) |
|
|
|
| MS |
|
12 (5.4) |
131 (51.9) |
|
|
|
| Bianchi [18]a |
296 |
|
|
various |
7mths-17yrs |
Not studied |
| Obesity |
|
111 (37.5) |
170 (57.4) |
|
|
|
| Diabetes mellitus |
|
29 (9.8) |
112 (37.8) |
|
|
|
| Laryea[21]a |
118 |
|
|
various |
3-18mths |
|
| Hypertension |
|
12 (10) |
72 (62) |
|
|
|
| Dyslipidemia |
|
4 (3) |
54 (46) |
|
|
|
| Diabetes mellitus |
|
15 (13) |
73 (61) |
|
|
|
| MS |
|
|
69 (58) |
|
|
More CVD |
| Hanouneh[22]a |
82 |
|
|
HCV recurrence |
1yr |
Not studied |
| Hypertension |
|
18 (19) |
61 (64.2) |
|
|
|
| Diabetes mellitus |
|
21 (22) |
49 (51.6) |
|
|
|
| MS |
|
|
41 (50) |
|
|
|
| Anastacio[23]b |
117 |
|
|
|
7yrs |
|
| AO |
|
|
51 (43.2) |
|
|
|
| Hypertension |
|
|
41 (34.7) |
|
|
|
| Diabetes mellitus |
|
|
29 (24.6) |
|
|
|
| Low HDL |
|
|
45 (44.6) |
|
|
|
| Abnormal TG |
|
|
34 (33.3) |
|
|
|
Legend: a: Retrospective study; b: Prospective study. TG: Triglycerides. AO: Abdominal Obesity. CVD: Cardiovascular Event. |
